Darbepoetin Alfa Simplifies Anemia Management!

New

Cresp

Cresp®(Biosimilar of darbepoetin alpha), a product by Dr. Reddy's is an erythropoiesis-stimulating agent which helps in treatment of renal anemia in pre-dialysis patients

Persistent CV Risk in Elevated Triglycerides Despite Statin Therapy: ICOS Solution

Mr. Basu’s case: a 54-year-old patient with diabetes, hypertension, and hyperlipidemia on statins, evaluated with...

ICOS: Reducing First, Subsequent, and Total CV Events in Dyslipidemia Management

Explore Ram's case to see how ICOS lowers first, subsequent, and total CV events in...

ICOS: Advanced Dyslipidemia Management for CV Risk Reduction

Explore Venu’s journey on statin therapy, where ICOS showed a 25% risk reduction in 5-Point...

ICOS: Added Heart Protection with NLA & AHA-Recommended Dyslipidemia Therapy

Discover how ICOS, an NLA and AHA-endorsed option, supports improved CV outcomes in patients with...

Balancing Act: Aspirin and Clopidogrel Cut Heart Risks But Raise GI Complications!

Heart Meds Cut Risks, Spark GI Issues Now!

@media (max-width:992px) and (min-width:768px) {}         @media (max-width:767px)...

Related Webinars

Darbepoetin Alfa Simplifies Anemia Management!

Related Articles

Login to continue